223 related articles for article (PubMed ID: 2567703)
1. CD2 and other surface molecules in the regulation of non-MHC-restricted cytolytic function.
Chan WC; Ye G; Link S; Mawle AC; Nicholson JK
Immunology; 1989 May; 67(1):56-61. PubMed ID: 2567703
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
[TBL] [Abstract][Full Text] [Related]
3. Role of CD2 in regulation of CD3- LGL function.
Mason A; Bernard A; Smyth MJ; Ortaldo JR
Eur Cytokine Netw; 1991; 2(1):31-7. PubMed ID: 1714784
[TBL] [Abstract][Full Text] [Related]
4. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.
Phillips JH; Lanier LL
J Immunol; 1986 Mar; 136(5):1579-85. PubMed ID: 2419407
[TBL] [Abstract][Full Text] [Related]
5. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
6. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
[TBL] [Abstract][Full Text] [Related]
7. CD2 is functionally linked to the zeta-natural killer receptor complex.
Vivier E; Morin PM; O'Brien C; Schlossman SF; Anderson P
Eur J Immunol; 1991 Apr; 21(4):1077-80. PubMed ID: 1673433
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
[TBL] [Abstract][Full Text] [Related]
9. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
[TBL] [Abstract][Full Text] [Related]
10. Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors.
Voltarelli JC; Gjerset G; Anasetti C
Immunology; 1993 Jul; 79(3):509-11. PubMed ID: 8104886
[TBL] [Abstract][Full Text] [Related]
11. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
[TBL] [Abstract][Full Text] [Related]
12. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
Uggla CK; Geisberg M; Jondal M; Knowles RW
Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
[TBL] [Abstract][Full Text] [Related]
13. Binding of monoclonal antibody to CD16 causes calcium mobilization in large granular lymphocytes but inhibits NK killing.
Macintyre EA; Wallace DW; O'Flynn K; Abdul-Gaffar R; Tetteroo PA; Morgan G; Linch DC
Immunology; 1989 Mar; 66(3):459-65. PubMed ID: 2564843
[TBL] [Abstract][Full Text] [Related]
14. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
15. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
[TBL] [Abstract][Full Text] [Related]
17. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
Schwarz RE; Hiserodt JC
J Immunol; 1988 Nov; 141(10):3318-23. PubMed ID: 3263421
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
[TBL] [Abstract][Full Text] [Related]
20. Lectin-dependent cell-mediated cytotoxicity and blastogenesis by large granular-enriched and depleted lymphocytes.
Perl A; Gonzalez-Cabello R; Laskay T; Benczur M; Láng I; Onódy K; Nékám K; Gergely P; Fehér J
Clin Exp Immunol; 1986 Jan; 63(1):171-8. PubMed ID: 3955881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
